Hong Kong SAR
-
China's CStone Pharmaceuticals is planning to float in Hong Kong, submitting a draft prospectus through sponsors Goldman Sachs and Morgan Stanley.
-
Online travel service provider Tongcheng-Elong Holdings is set to launch a truncated Hong Kong IPO on Tuesday after key comparable Ctrip’s stock price collapsed amid volatility last week, according to a source close to the deal.
-
In this round-up, China’s foreign reserves in October decrease $34bn due to the stronger dollar, monthly exports climbed more than expected, Singapore Exchange signed cooperation agreements to develop more opportunities for Chinese enterprises in Singapore.
-
The China Securities Regulatory Commission has given Tianqi Lithium the go ahead to list on the Hong Kong Stock Exchange.
-
Goldman Sachs has restructured its capital markets teams in Asia, naming new co-heads for the equity and credit units.
-
UBS hires for China strategy – New tech board for Shanghai – HKEX eyes blockchain for Stock Connect – PBoC warns against Evergrande, Fosun, HNA
-
Hong Kong-listed Man Wah Holdings and China Water Affairs Group are seeking offshore loans of $100m and $200m respectively.
-
I’ll admit I often took pleasure in firing an underling back in my day, feeling a perverse sense of satisfaction in asserting my authority and punishing wrongdoers.
-
Hong Kong Exchanges and Clearing (HKEX) has partnered with Digital Asset to develop a post-trade settlement and allocation system based on blockchain technology. It will cover northbound trading on Stock Connect.
-
The People's Bank of China's Rmb20bn ($2.9bn) debut bill auction in Hong Kong showed investors are increasing their yield demands in the offshore renminbi market.
-
Wendy Liu has joined UBS’s research arm as managing director and head of China strategy, according to a memo seen by GlobalCapital Asia.
-
Goldman Sachs has restructured its capital markets teams in Asia, naming new co-heads for the equity and credit businesses.